UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005873
Receipt number R000006938
Scientific Title Phase I Study of Irinotecan and Erlotinib in Patients with Erlotinib Failure for EGFR Mutations Non-Small Cell Lung Cancer
Date of disclosure of the study information 2011/06/29
Last modified on 2023/01/06 14:47:27

No. Disposal Last modified on Item of update
1 Insert 2011/06/29 10:16:33
2 Update 2023/01/06 14:23:02 1st name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Email


Last name of contact person
Zip code
Homepage URL
Email
Name of primary person or sponsor
Institute
Department
Organization
Organization
Organization
Address
Address
Tel
Email
3 Update 2023/01/06 14:46:44 Recruitment status
Date of IRB
Last follow-up date
4 Update 2023/01/06 14:47:27 Number of participants that the trial has enrolled